CD22 Recombinant antilichaam [hL22 (Epratuzumab) ] (OAAV00410)
Gecertificeerd

CD22 Recombinant antilichaam [hL22 (Epratuzumab) ] (OAAV00410)

Catalog #: OAAV00873-200UG
Maat: 200 µg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

Gene Name

GM2 ganglioside

Reactivity

Human

Immunogen

L55-81 was prepared by isolating EBV-immortalized peripheral blood B lymphocytes from a human donor with melanoma.

Target

This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format, for improved compatibility with existing reagents, assays and techniques.

Clonality

• Recombinant Monoclonal

Clone

L55-81

Type

Recombinant Monoclonal Antibody

Purification

Purified

Assay Protocol

Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Reconstitution & Storage Instructions Reconstitution & Storage Instructions Western Blotting/Immunoblotting (WB/IB) Protocol Western Blotting/Immunoblotting (WB/IB) Protocol Immunohistochemistry (IHC) Protocol Immunohistochemistry (IHC) Protocol Immunocytochemistry (ICC) Protocol Immunocytochemistry (ICC) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol Blocking Peptide Competition Protocol (BPCP) Blocking Peptide Competition Protocol (BPCP) Immunoprecipitation (IP) Protocol Immunoprecipitation (IP) Protocol Antibody Array (AA) Protocol Antibody Array (AA) Protocol

Concentration

1 mg/ml

Dilution

OAAV00429 reacts positively to melanoma cell lines with high GM2 expression (M14; M24), and shows no binding to normal cell types or cell lines M15 or M25 which have low GM2 expression and high GM3 expression. This specificity can be confirmed by ELISA and TLC immunostaining by testing a variety of gangliosides and neutral glycolipids. OAAV00429 is able to lyse cells from the M14 melanoma cell line (which has high GM2 expression) in the presence of human or rabbit complement, but not in the absence of complement - this was shown by a [51Cr] release assay. Biotinylated OAAV00429 has been used for IHC of acetone-fixed sections of tumor tissue in an avidin-biotin complex immunoperoxidase system. Statistically significant positive staining (determined by Fisher's exact test) was displayed with melanoma, colon carcinoma and ovary carcinoma tumor tissues. Staining has also be observed with breast carcinoma, prostate carcinoma and kidney carcinoma.

Format

Liquid// PBS with 0.02% Proclin300

Reconstitution

Store at 4° C for up to 3 months. For longer storage, aliquot and store at -20° C.

Fragment

IgG, kappa

Specificity

OAAV00429 binds specifically to GM2 ganglioside; this antibody shows no reactivity towards GM1, GM3, GD2 or normal tissues- the OAAV00429 epitope contains both a GalNAc and sialic acid bound to lactose. Ganglioside GM2 (GalNAc-beta-1-4 (NeuNAca2-3) Gal-beta-1-4Glc-beta-1ceramide) is a glycosphingolipid present on the cell surface and a major tumor-differentiation antigen in human melanoma and hepatoma.

Host or Source

Rabbit

Preparation

This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format, for improved compatibility with existing reagents, assays and techniques.

Beschrijving

CD22 Recombinant antilichaam [hL22 (Epratuzumab) ] (OAAV00410) Beschikbaar in 200 µg. Bestel eenvoudig online met snelle levering.

Specificaties

ProductnaamCD22 Recombinant antilichaam [hL22 (Epratuzumab) ] (OAAV00410)
Categorie
Beschikbare grootte200 µg
CatalogusnummerOAAV00873-200UG